Dec 26, 2024 by Adam Spatacco Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear. Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, ...

Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year ...

Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

Less-than-stellar phase 3 results with Novo Nordisk's highly anticipated obesity therapy CagriSema have caused its shares to fall by over a fifth, wiping around $94 billion off its market cap.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Danish pharma group Novo Nordisk has revealed it is in exclusive negotiations that could result in the acquisition of a controlling stake in Biocorp, a French company that makes medical devices ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

2024 blev det dårligste år for Novo Nordisk siden 2018. Efter årets sidste handelsdag står det klart, at årets afkast for Novo-aktionærerne blev negativt. Aktien er faldet med 10,6 pct. i 2024. Ikke ...

Med virkning fra den 7. januar 2025 ændres kuponrenten på variabelt forrentede obligationer udstedt af Nykredit Realkredit A/S. Obligationer med kvartårlig rentefastsættelseDe nye kuponrenter er ...